Clinical trial
A Randomized Controlled Study of the Safety and Efficacy of Neurostimulation Using a Vagus Nerve Stimulation Device in Patients With Rheumatoid Arthritis
NCT03437473 is registered in ClinicalTrials.gov with SetPoint Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study of the Safety and Efficacy of Neurostimulation Using a Vagus Nerve Stimulation Device in Patients With Rheumatoid Arthritis
- Lead sponsor
- SetPoint Medical Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 6, 2018
- Completion date
- December 10, 2018
- Enrollment
- 14 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis